Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | GBA1 | P04062 | 3/20 | 0.43 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17589589 | 0.87 | PDE10A (0.53) | CYP1A2MEN1ALDH1A1TSHRKMT2A | |
| SCHEMBL17035148 | 0.84 | CYP1A2 (0.45) | CYP1A2CYP3A4CYP2D6CYP2C9CLK4 | |
| SCHEMBL17034962 | 0.83 | DHODH (0.49) | CYP1A2CYP3A4CYP2D6CYP2C9CLK4 | |
| SCHEMBL17034960 | 0.80 | CYP11B1 (0.48) | CYP1A2CYP3A4CYP2D6CYP2C9CLK4 | |
| SCHEMBL17035023 | 0.80 | CYP11B1 (0.48) | CYP1A2CYP3A4CYP2D6CYP2C9CLK4 | |
| SCHEMBL17034961 | 0.80 | DHODH (0.49) | CYP1A2CYP3A4CYP2D6CYP2C9CLK4 | |
| SCHEMBL17034965 | 0.79 | CYP11B1 (0.43) | CYP1A2CYP3A4CYP2D6CYP2C9CLK4 | |
| SCHEMBL17034888 | 0.78 | CYP11B1 (0.49) | CYP1A2CYP3A4CYP2D6CYP2C9CLK4 | |
| SCHEMBL17589586 | 0.78 | DHODH (0.43) | CYP1A2CYP3A4CYP2C9HSD17B10MEN1 | |
| SCHEMBL17034967 | 0.78 | HPGD (0.44) | CYP1A2CYP3A4CYP2D6CYP2C9CLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9899611-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-02-20 | — | — | US | disclosed |
| US-20160079546-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160079546-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | CYP1A2 907/4885CYP3A4 1007/4885CYP2D6 2102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.